A post treatment tumor specimen obtained from our NC patient at day 98 revealed (i) a partial necrosis, (ii) a switch from a CD3+CD4+ dominant to a CD3+CD8+ dominant lymphocyte infiltrate as well as (iii) an increased number of tumor infiltrating macrophages (Figure S1 and S2). The gene discussed is CD8A; the disease is neoplasm.